Literature DB >> 737894

Effect of cyclophosphamide on Toxoplasma gondii infection: reversal of the effect by passive immunization.

A Hafizi, F Z Modabber.   

Abstract

Treatment of mice with cyclophosphamide (CY) at a dose of 250 mg/kg body weight 24 hr prior to infection with an avirulent strain of Toxoplasma gondii delays the appearance of antibody by about one week and results in 70% mortality. To discount other effects of CY besides inhibition of antibody synthesis, CY-treated infected mice were passively immunized with a pooled specific serum collected from chronically infected syngeneic animals. Passive immunization reversed the effect of CY treatment if the titre of antibody in recipients reached 1 : 512 or more, as measured by the indirect immunofluorescence technique (IFT). It is therefore suggested that antibody plays an important role in establishing an infection-immunity (premunition) in this system.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 737894      PMCID: PMC1537435     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Modulation of delayed-type hypersensitivity and cellular immunity to microbial vaccines: effects of cyclophosphamide on the immune response to tularemia vaccine.

Authors:  M S Ascher; D Parker; J L Turk
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

2.  Effects of variation in time and dose of cyclophosphamide injection on delayed hypersensitivity and antibody formation.

Authors:  J A Kerckhaert; F M Hofhuis; J M Willers
Journal:  Cell Immunol       Date:  1977-03-15       Impact factor: 4.868

3.  Toxoplasmic lymphadenitis in Iran.

Authors:  M Ghorbani; A H Samii
Journal:  J Trop Med Hyg       Date:  1973-07

4.  Adoptive immunity to intracellular infection.

Authors:  J K Frenkel
Journal:  J Immunol       Date:  1967-06       Impact factor: 5.422

5.  The effect of cyclophosphamide on the recovery from a local chlamydial infection. Guinea-pig inclusion conjunctivitis (GPIC).

Authors:  F Modabber; S E Bear; J Cerny
Journal:  Immunology       Date:  1976-06       Impact factor: 7.397

6.  Specific antibody-dependent killing of Toxoplasma gondii by normal macrophages.

Authors:  S E Anderson; S C Bautista; J S Remington
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

7.  Effect of antithymocyte serum on experimental toxoplasmosis in mice.

Authors:  O Strannegård; E Lycke
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

8.  Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide.

Authors:  P H Lagrange; G B Mackaness; T E Miller
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

9.  Staining Toxoplasma gondii with fluorescein-labelled antibody. I. The reaction in smears of peritoneal exudate.

Authors:  M GOLDMAN
Journal:  J Exp Med       Date:  1957-06-01       Impact factor: 14.307

10.  Effect of normal and activated human macrophages on Toxoplasma gondii.

Authors:  S E Anderson; J S Remington
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

View more
  3 in total

1.  Lack of immunoglobulin M suppression by immunoglobulin G antibody in thymectomized, irradiated, and bone marrow-reconstituted mice infected with Toxoplasma gondii.

Authors:  J Aryanpour; A Hafizi; F Modabber
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

2.  Immunological response in experimentally reactivated toxoplasmosis in mice.

Authors:  M Goyal; N K Ganguly; R C Mahajan
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

3.  Immunosuppression with cyclophosphamide favors reinfection with recombinant Toxoplasma gondii strains.

Authors:  L A Silva; G P Brandão; B V Pinheiro; R W A Vitor
Journal:  Parasite       Date:  2012-08       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.